• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver

    2021-11-08 08:33:40ZhongHuWngKnnthZhngXioDongWngJinQioYngYngLiLiZhngMingHuZhngJinWu

    Zhong-Hu Wng ,Knnth I Zhng ,Xio-Dong Wng ,,,Jin Qio ,Yng-Yng Li ,Li Zhng ,Ming-Hu Zhng ,,,Jin Wu ,g,h,?

    a Department of Medical Microbiology and Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai 20 0 032, China

    b NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 3250 0 0, China

    c Institute of Hepatology, Wenzhou Medical University, Wenzhou 3250 0 0, China

    d Th e Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou 3250 0 0, China

    e Department of General Practice, Huaihai Middle Road Community Health Service Center of Huangpu District, Shanghai 20 0 025, China

    f Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 3250 0 0, China

    g Department of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai 20 0 032, China

    h Laboratory of Fatty Liver and Metabolic Diseases, Shanghai Institute of Liver Diseases, Fudan University Shanghai Medi cal College, Shanghai 20 0 032, China

    Keywords: Lipidomics Nonalcoholic steatohepatitis Nonalcoholic fatty liver disease Biomarker Nonalcoholic activity score Hepatic fibrosis

    ABSTRACT Background: Nonalcoholic fatty liver disease (NAFLD) is one of the main liver diseases, and its pathologic profile includes nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). However, there is no reliable non-invasive parameter in distinguishing NASH from NAFL in clinical practice. The present study was to find a non-invasive way to differentiate these two categories of NAFLD via lipidomic analysis. Methods: Lipidomic analysis was used to determine the changes of lipid moieties in blood from 20 NAFL and 10 NASH patients with liver biopsy. Liver histology was evaluated after hematoxylin and eosin stain-ing and Masson’s trichrome staining. The profile of lipid metabolites in correlation with steatosis, inflam-mation, hepatocellular necroptosis, fibrosis, and NAFLD activity score (NAS) was analyzed. Results: Compared with NAFL patients, NASH patients had higher degree of steatosis, ballooning de-generation, lobular inflammation. A total of 434 different lipid molecules were identified, which were mainly composed of various phospholipids and triacylglycerols. Many lipids, such as phosphatidyl-choline (PC) (P-22:0/18:1), sphingomyelin (SM) (d14:0/18:0), SM (d14:0/24:0), SM (d14:0/22:0), phos-phatidylethanolamine (PE) (18:0/22:5), PC (O-22:2/12:0), and PC (26:1/11:0) were elevated in the NASH group compared to those in the NAFL group. Specific analysis revealed an overall lipidomic profile shift from NAFL to NASH, and identified valuable lipid moieties, such as PCs [PC (14:0/18:2), PE (18:0/22:5) and PC (26:1/11:0)] or plasmalogens [PC (O-22:0/0:0), PC (O-18:0/0:0), PC (O-16:0/0:0)], which were signifi-cantly altered in NASH patients. In addition, PC (14:0/18:2), phosphatidic acid (18:2/24:4) were positively correlated with NAS; whereas PC (18:0/0:0) was correlated positively with fibrosis score. Conclusions: The present study revealed overall lipidomic profile shift from NAFL to NASH, identified valuable lipid moieties which may be non-invasive biomarkers in the categorization of NAFLD. The cor-relations between lipid moieties and NAS and fibrosis scores indicate that these lipid biomarkers may be used to predict the severity of the disease.

    Introduction

    Nonalcoholic fatty liver disease (NAFLD) is one of the main liver diseases and its pathologic profile ranged from nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH) with varying de-grees of fibrosis and, in some cases, to cirrhosis [1] . NAFLD has be-come the most common metabolic disease underlying obesity, dys-lipidemia, metabolic syndrome and type 2 diabetes with a preva-lence of 15% in China [2],and 30% or higher in the North America and Europe [ 3–5 ]. The main difference between NASH and NAFL is the presence of hepatic inflammation, hepatocellular injury and cell death. Approximately 25% of patients with NAFL may develop NASH, 15%-20% of patients with NASH may further progress to fi-brosis and eventually cirrhosis, and at least 1%-2% of them may develop to HCC each year [ 3,5 ]. The progression from NAFL to NASH with fibrosis is a manifestation of disease activity, and the severity of liver fibrosis is a long-term determinant of complica-tions and death in NASH patients [ 6–8 ]. Thus, it is crucial to iden-tify NASH patients with fibrosis and take preventive measures to stop or reverse NASH progression. However, it is difficult to dis-tinguish NASH from NAFL with current laboratory tests and imag-ing modalities, and often requires invasive liver biopsy. Therefore, novel biomarkers are needed for noninvasive differentiating diag-nosis of NASH from NAFL and assessment of treatment responses in clinical practice.

    Metabolomics has drawn great scientific attention due to its powerful measurement of numerous metabolites at accurate levels. Metabolomic methodology allows to understand overall metabolic alterations during the transition from healthy liver, NAFL to NASH [9] . Lipidomics is an important branch of metabolomics. It accurately analyzes the changes of lipid metabolites, determines the characteristics of lipid metabolism in different stages of dis-ease progression, and identifies valuable diagnostic indicators. As a metabolic disorder, NASH possesses tremendous metabolic ab-normalities in carbohydrates, lipids and other metabolites. General metabolomics may provide an overall profile of metabolic changes; whereas lipidomic analysis with ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS/MS) is able to re-veal lipids that are not seen in established analytical techniques, thus, may identify unusual lipid metabolic pathways or possible biomarkers for differentiating NASH from NAFL [10] . Moreover, routine lipid panels in clinical laboratory only examine limited range of lipids in the liver or bloodstream, and substantial changes in numerous lipids outside of these moieties are not commonly measured in a metabolomic panel. Given the important biological activity among lipids, especially for lipid species that are not rec-ognized, such as in informatory signaling pathways, lipidomic anal-ysis in pathologically confirmed patients may provide deep insights into the pathophysiology in the transition from NAFL to NASH as well as further fibrotic progression [11] . To explore the differenti-ating potential of lipidomic analysis in NAFLD patients, the UHPLC-MS/MS lipidomic platform was used to measure serum lipids of NASH patients and NAFL controls with liver biopsy, and to explore the relationship between abnormalities in blood lipid metabolism and extent of steatohepatitis and fibrosis in NASH patients. The ul-timate goal is to identify new biomarkers for noninvasive diagnosis and effective prevention of NASH.

    Materials and methods

    Patients and sample collection

    Human serum samples of this study were obtained from the First Affiliated Hospital of Wenzhou Medical University. The study was approved by the Institutional Review Board of the First Affili-ated Hospital of Wenzhou Medical University and the Ethics Com-mittee of Fudan University School of Basic Medical Sciences. In our study, all subjects were enrolled in accordance with ethical guide-lines, and written informed consent was obtained prior to the par-ticipation. All clinical procedures involved in this study were per-formed in accordance with the relevant guidelines and regulations. All subjects were ruled out of alcoholic liver or other causes of liver diseases (hepatitis B, or C infection, autoimmune hepatitis, drug toxicity, etc.) by methods previously described [12] .

    According to liver histology, serum from 30 subjects was di-vided into two groups: NAFL control group (n= 20) and NASH group (n= 10). Blood samples were collected from subjects who were fasted overnight (8 h) and placed in cold tubes containing ethylene diamine tetraacetic acid (EDTA) (6 mmol/L). Serum was separated by centrifugation (2500 rpm, 15 min) and aliquots were immediately frozen at -80 °C until analysis (avoiding repeated freezing and thawing) [13] . Table 1 summarizes the demographic information and results of clinical laboratory parameters of the enrolled subjects, including NAFLD activity score (NAS), index of homeostasis model assessment insulin resistance (HOMA-IR), con-trolled attenuation parameter (CAP) from ultrasound stiffness ex-amination, and semiquantitative score of fibrosis. The calculation of HOMA-IR was made according to the formula as described pre-viously [14] .

    Table 1 Clinical and biological characteristics of NASH and NAFL patients.

    Ultrasonographical examination for hepatic steatosis

    All patients have undergone sonographic examination for hep-atic fatty content measurement of CAP by a well-trained special-ist. The CAP measures ultrasonic attenuation in the liver at 3.5 MHz using signals acquired by the FibroScan?M probe based on vibration-controlled transient elastography (VCTETM). The princi-ples were described previously [15] .

    Tissue staining of liver biopsy

    An ultrasound-guided liver biopsy was performed under se-dation using an 18-gauge Hepafix needle (Gallini, Modena, Italy). Biopsy specimens were fixed in 10% formalin, embedded in paraf-fin, cut and stained with hematoxylin and eosin and Masson’s trichrome. Histopathology of all biopsies was examined by an ex-perienced and board-certified liver pathologist (Dr. Yang-Yang Li), who was blinded to clinical and laboratory data of participants. The histologic features of NAFLD were scored according to the NASH Clinical Research Network classification [16] . Each slide was evaluated for two aspects, NAS (0–8) and fibrosis stage (1–4). NAS was calculated based on the unweighted sum of the scores for steatosis (0–3), lobular inflammation (0–3) and hepatocellular bal-looning (0–2) [16] . Fibrosis was staged in both HE and trichrome staining sections according to Ludwig’s and Scheuer’s classifica-tions, from 0 to 4: 0 = no fibrosis; 1 = perisinusoidal or portal fi-brosis; 2 = perisinusoidal and portal/periportal fibrosis; 3 = bridg-ing fibrosis; 4 = highly suspicious or definite cirrhosis [ 17–19 ]. If NAS of a liver specimen is ≥5, the section is defined as “NASH”. If NAS is ≤4, it represents as “NAFL”[16] . All stained sections were photographed under light microscopy with ×200 amplification.

    Non-targeted lipidomics

    The ultra-high performance liquid tandem chromatography quadrupole time of flight mass spectrometry (UHPLC-QTOF/MS) analysis was performed utilizing an UHPLC system (1290 series, Agilent Technologies, Santa Clara, CA, USA) coupled to a quadru-ple time-of-flight (QTOF) mass spectrometer (Agilent 6550 iFunnel QTOF, Agilent Technologies). A Waters ACQUITY UPLC BEH Amide column [particle size, 1.7μm; 100 mm (length) ×2.1 mm (i.d.)] was used for the lipid extract (LE) separation, and the column temperature was maintained at 25 °C. The flow rate was set as 0.6 mL/min, and the sample injection volume was 2μL. The mo-bile phase A was 25 mM ammonium hydroxide (NH4OH) + 25 mM ammonium acetate (NH 4 OAc) in water, and B was acetonitrile (ACN) in positive mode (ESI + ). The gradient was set as follows: 0–0.5 min, 95% B; 0.5–7 min, 95% B to 65% B; 7–8 min, 65% B to 40% B; 8–9 min, 40% B; 9–9.1 min, 40% B to 95% B; 9.1–12 min, 95% B. The acquisition rate was set as 4 spectra/second, and the time-of-fight (TOF) mass range was set as m/z 50–1200 Da in a positive mode. The parameters of mass spectrometry (MS) data ac-quisition were set as follows: sheath gas temperature, 400 °C; dry gas temperature, 250 °C; sheath gas flow, 12 L/min; dry gas flow, 16 L/min; capillary voltage, 30 0 0 V; nozzle voltage, 0 V; and neb-ulizer pressure, 20 psi. Tandem mass spectrometry (MS/MS) data acquisition was performed using another QTOF S2 mass spectrom-eter (Triple TOF 5600 +,AB SCIEX, USA). Quality control samples were used for MS/MS data acquisition. To expand the coverage of MS/MS spectra, the mass range was divided into 4 segments: 50–30 0 Da, 290–60 0 Da, 590–90 0 Da, and 890–1200 Da. The acquired MS/MS spectra were matched against in-house tandem MS/MS li-brary for metabolite identification. The source parameters were set as follows: GAS1, 60; GAS2, 60; CUR, 30; TEM, 600 °C; and ISVF, 5500 V [20] . The analysis was performed in the Lipidomics Service Platform [21],Shanghai Life Science Institutes, Chinese Academy of Sciences, Shanghai, China.

    Raw data preprocessing

    The ionization source of the LC-QTOFMS platform is electro-spray ionization. There are two ionization modes: positive ion mode (POS) and negative ion mode (NEG). The raw data of the pos-itive ion mode contained 4 quality control samples, 20 NAFL and 10 NASH samples. A total of 327 peaks were extracted from them. In order to better analyze the data, a series of preparation and data management on the original data were undertaken. They mainly included the following steps: (1) filtering a single peak to remove noise. The deviation was filtered based on the relative standard de-viation (RSD), or coefficient of variation (CV). (2) Filtering on a sin-gle peak. Only peak area data with no more than 50% null values in a single group or no more than 50% null values in all groups were retained. Missing value recoding was performed on the orig-inal data. The numerical simulation method was to fill in half of the minimum value. Data normalization was performed using the total ion current (TIC) of each sample. After preprocessing, 327 sta-tistically significant peaks were retained.

    Statistical analysis

    All statistical analyses were conducted using the SPSS Version 2.0 (SPSS, Chicago, IL, USA). Data were presented as means ±stan-dard deviation (SD) or frequencies. Baseline characteristics of the study population were compared using the one-way ANOVA analy-sis for continuous variables. The final dataset containing the infor-mation of peak number, sample name and normalized peak area were imported to SIMCA15.0.2 software package (Sartorius Stedim Data Analytics AB, Ume?, Sweden) for multivariate analysis. Data were scaled and logarithmic transformed to minimize the impact of both noise and high variance of the variables. After these trans-formations, principle component analysis (PCA) was carried out to visualize the distribution and the grouping of the samples. We used 95% confidence interval in the PCA score plot as the thresh-old to identify potential outliers in the dataset. In order to visualize group separation and find significantly altered metabolites, super-vised orthogonal projection to latent structures-discriminate anal-ysis (orthogonal partial least-square, OPLS-DA) was applied. Then, a 7-fold cross validation was performed to calculate the value of R2and Q2. R2indicates how well the variation of a variable is ex-plained and Q2means how well a variable could be predicted. To check the robustness and predictive ability of the OPLS-DA model, 200 times of permutations were further conducted. Afterward, the R2and Q2intercept values were obtained. Here, the intercept value of Q2represents the robustness of the model, the risk of over-fitting and the reliability of the model, and the smaller the bet-ter. Furthermore, the value of variable importance in the projec-tion (VIP) of the first principal component in OPLS-DA analysis was obtained. It summarizes the contribution of each variable to the model. The metabolites with VIP>1 andP<0.05 (Student’sttest) were considered as significantly altered. Spearman rank cor-relation was used to analyze the correlation between lipids and liver pathological scores. At the same time, the lipidomic data were also verified by the PLS-DA model to confirm suitability and lia-bility of OPLS-DA modeling (Fig. S1) [22] . As shown in the figure, the PLS-DA model was used to re-analyze the data from two NASH and NAFL groups. Through the analysis, it is clear that there is no significant difference in the first and second principal component analyses between the groups. The parameters (PLS-DA model pa-rameter table) used in PLS-DA analysis are the same as in the pre-vious OPLS-DA model. The only difference is that PLS-DA lacks pos-itive exchange calculation analysis; whereas OPLS-DA model may filter out the signals that are not related to the model classifica-tion, hence its interpretation ability is stronger than PLS-DA.

    Fig. 1. Lipid profiles of serum samples from the NAFL and NASH groups and preliminary data processing. A: Proportion of major lipid components. B: Principal component analysis (PCA) score plot of metabolic profile of the NASH and NAFL groups after mean-centering and not (Ctr) scaling. C: OPLS-DA score plot of lipid profile of the NASH and NAFL groups after unit variance (uv) scaling. D: Score plot of OPLS-DA model obtained from C . The resulting R 2 and Q 2 values were plotted. The red dots represent the R 2 Y values obtained from the displacement test; the blue square dots represent the Q 2 values obtained from the displacement test; and the two dashed lines represent the regression lines of R 2 Y and Q 2,respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

    Fig. 2. Heatmap of hierarchical cluster analysis of differential metabolites in the NASH and NAFL groups. The columns at the left side of the solid line represent the samples from the NASH group; while those at the right side of the solid line represent the samples from the NAFL group. Levels of the discriminating metabolites in all samples are shown in color. Up-regulated metabolites are presented with the red color, while the down-regulated metabolites are shown with the blue color. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).

    Results

    Demographics

    Thirty NAFLD patients (20 cases of NAFL and 10 cases of NASH) were included in the present study. The detailed baseline charac-teristics including demographics, body mass index (BMI), biochem-ical tests, HOMA-IR, CAP value and histopathologic description of liver biopsy from all patients are detailed in Table 1 . It is clear that NASH patients had a higher BMI (P= 0.02), higher serum levels of AST/ALT ratio (P= 0.05) and slightly higher GGT (P>0.05) than NAFL patients. Fasting serum insulin levels tended to be higher in NASH patients than NAFL patients, however, statistical analysis did not show any significance (P>0.05). Routine liver biochemical and metabolic tests [such as serum glucose, bilirubin, high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG), total cholesterol did not significantly differ between the NASH and NAFL groups ( Table 1 ). Due to very close serum glucose and fast-ing insulin levels, HOMA-IR did not show any difference between these two groups although both of them were above the normal range (5.80 and 8.17), and there was a tendency that NASH patients had a more severe insulin resistance than NAFL patients. Compared to the NAFL group, patients in NASH group had much higher NAS levels with a severe degree of steatosis (CAP and histology), bal-looning degeneration, lobular inflammation, and there was a ten-dency that NASH group had higher semiquantitative score of hep-atic fibrosis in Masson’s staining. Thus, AST/ALT ratio, CAP read-ing, NAS and extent of fibrosis were separable in patients between NAFL and NASH, and were consistent with clinical and patholog-ical diagnosis. As the most reliable pathologic variables, NAS and semi-quantitative fibrosis score were used as two major references to determine differential values of lipidomic measurements as well as the base for correlation analysis, although there was no sig-nificantly statistical difference in fibrosis score between these two groups.

    Composition of serum lipid extracts

    A total of 434 different lipid molecules, which were predom-inantly composed of various phospholipids (PLs), were identi-fied from analyzed serum samples. There were 166 phosphatidyl-cholines (PC), 108 phosphatidylethanolamines (PE), 59 sphin-gomyelins (SM), 37 lyso-phosphatidylcholines (LPC), 21 phos-phatidylglycerols (PG), 17 phosphatidylinositols (PI), 13 phospha-tidic acids (PA), 12 lyso-phosphatidylethanolamines (LPE), and 1 phosphatidylserines (PS) in the identified lipid pool, which were further analyzed. The percentage of each lipid in the total pool is shown in Fig. 1 A and Table S1.

    The results of multivariate statistical analysis

    To evaluate whether NASH affects lipid synthesis and compo-sition, 327 peaks remained after the removal of noise based on the interquartile range and normalization using TIC of each sam-ple. After obtaining the collated data, a series of multivariate pat-tern recognition analysis was undertaken. First, PCA was initially applied to the spectra to visualize inherent clustering between the NAFL control and NASH groups. As shown in the PCA score map, the isolated samples were basically within the 95% confi-dence interval (Hotelling’s T-squared ellipse); however, there was some overlap between the NAFL and NASH groups ( Fig. 1 B). In order to obtain a high level of group separation and for a better understanding of the variables responsible for classification, super-vised OPLS-DA was applied. From the OPLS-DA score ( Fig. 1 C), it is evident that isolated samples have a clear separation between these two groups. Then it was further verified whether the model established in this way reflects the actual situation of the lipid data by OPLS-DA permutation test. As shown in Fig. 1 D, the original R2Y model was very close to 1, indicating that the OPLS-DA model was consistent with the actual situation of the lipid data. In general, the original model may explain the differences in lipid distribution between these two groups in convincing robustness and there was no over-fitting phenomenon (R2Y = 0.65).

    Dif ferences in lipid metabolites between the NAFL and NASH groups

    In order to find out the lipid moieties whose concentrations were altered in the NASH group compared to those in the NAFL group, all the ion peaks were defined with their VIP in the OPLS-DA model, which was superior to 1. A Student’sttest was performed between these two groups. Peak areas withPvalue higher than 0.05 were excluded as indicated in Fig. S2. Then the heatmap was created to perform hierarchical clustering analysis on such features ( Fig. 2 ), which aids in classifying lipid moieties with the same features into one class and exhibits the signifi-cant difference between the NASH and NAFL groups. From the heatmap, it is clear that PC (P-22:0/18:1) (1.3:1,P= 0.037), SM (d14:0/18:0) (1.3:1,P= 0.003), SM (d14:0/24:0) (1.4:1,P= 0.012), SM (d14:0/22:0) (1.6:1,P= 0.033), PE (18:0/22:5) (1.4:1,P= 0.025), PC (O-22:2/12:0) (1.4:1,P= 0.045), and PC (26:1/11:0) (P= 0.011) in the NASH group were significantly higher than the NAFL group. Whereas PC (22:6/0:0) (0.6:1,P= 0.0 0 01), PC (16:1/0:0) (0.7:1,P= 0.001) and SM (d14:0/12:0) (0.77:1,P= 0.023) in the NASH group were lower than the NAFL group. Therefore, the value of these lipid moieties appears to be differentially distributed be-tween the NASH and NAFL groups. Relevant data are shown in Ta-ble S1.

    Fig. 3. Pathological staining and correlation analysis. A: Masson trichrome and hematoxylin-eosin (HE) staining of liver biopsy tissue from the NASH and NAFL groups. a, b, e, f represent the samples from the NAFL group, while c, d, g, h represent the samples from the NASH group. B : Correlation between lipid changes and liver pathological scores. FS: fibrosis score. Negative and positive regression value is presented in color. NAS: NAFLD activity score. Images were taken at original magnification ( ×200). Scale bars = 60 μm ( e,f,g,h )

    Hepatocellular steatosis and fibrosis in NAFL and NASH

    To determine the extent of hepatic fibrosis, Masson’s trichrome staining of liver biopsy tissue was performed. It is evident that collagenous fibrils were deposited in the pericellular space in the NASH group ( Fig. 3 Ac,d), which was more severe than the NAFL group ( Fig. 3 Aa,b). Hepatocytes in the NASH group appeared to be steatotic in severe degrees as shown by HE staining ( Fig. 3 Ag, h), whereas steatosis in the NAFL group ( Fig. 3 Ae, f) was mild and less visible in comparison to the NASH group. Thus, the main patho-logic difference of NASH from NAFL was the severity of steatosis, occurrence of inflammatory reaction, and fibrotic progression as observed in HE and Masson’s staining, and they were well reflected by NAS and fibrosis scores in Table 1 . The statistical difference in NAS between the NASH and NAFL groups was striking (P<0.0 0 01 in NAS), although the fibrosis score did not reach statistical sig-nificance (P= 0.08). The NAS and fibrosis score are well-accepted semiquantitative parameters to reflect the severity of NASH with fibrotic progression.

    Correlation between lipid changes and semi-quantitative scores of pathological assessments

    NAS and fibrosis scores were used to further define whether al-tered profile of lipid metabolites in the NASH group reflects un-derlying pathologic changes of steatosis, inflammation, hepatocel-lular necroptosis, and fibrosis. As shown in Fig. 3 B, PE (18:0/22:5) and PC (14:0/18:2) are positively correlated with NAS (regression values: 0.46 and 0.43,P= 0.01, respectively). In contrast, PCs (sat-urated or monounsaturated), such as PC (22:6/0:0), PC (20:4/0:0) and PC (16:1/0:0) were negatively correlated with NAS (regression value: -0.56, -0.58 and -0.56,P= 0.0 01, 0.0 0 06 and 0.0 01, respec-tively). Of note, PC (18:0/0:0) was positively correlated with liver fibrosis score (regression value: 0.36,P= 0.04). Moreover, a large proportion of plasmalogens, such as PC (O-22:2/16:1) and PC (O-22:0/0:0) were negatively correlated with liver fibrosis scores (re-gression values: -0.45 and -0.41,P= 0.01 and 0.02, respectively). In summary, lipid moieties are differentially distributed in the NASH and NAFL groups with positive or negative correlation to the sever-ity of NASH and fibrosis progression. These correlations may im-ply pathophysiologic importance and potential clinical references of significantly altered lipid moieties as biomarkers for NASH pro-gression. Presumably, a combination of these lipid moieties may help to differentiate NASH from NAFL.

    Discussion

    It is well known that the changes in lipid homeostasis, such as cholesterol esters, TG, diacylglycerol, and sphingomyelin in blood and liver tissues are the feature of NAFLD [ 23–26 ]. Existing studies have shown that there are significant differences in lipid profiles between healthy subjects and NAFLD patients [10] . However, it re-mains a real challenge in using lipid data to distinguish NASH from NAFL patients. The biological effects of changes in lipid composi-tion are very complex and multifaceted, and depend on their rel-ative cellular and subcellular locations [ 27,28 ]. They may function as key signaling molecules, transcription regulators or check-point substances in metabolism, immunity, or cellular responses [ 29–31 ]. They may further affect membrane fluidity. Lipid peroxidation may occur under oxidant stress, and cause lipotoxicity [32] .

    Several studies employing metabolomics or lipidomics are avail-able to determine metabolic or lipidomic profile changes among controls, NAFL and NASH [ 33–35 ]. Puri and colleagues demon-strated that [33] serum 5-hydroxyeicosatetraenoic acid (5-HETE), 8-HETE, and 15-HETE are increased in a stepwise manner in the progression from normal to NAFL, further to NASH. Our present study identified the differences in lipid characteristics between NAFL and NASH patients. Through rigorous statistical analysis, we found that phospholipids: PC (P-22:0/18:1), PC (26:1/11:0), PE (18:0/22:5) and PE (18:0/22:5) were increased in patients with NASH; whereas PC (22:6/0:0), PC (16:1/0:0) and SM (d14:0/12:0) were decreased in these patients compared to NAFL. Therefore, NASH lipidomic profile was much shifted from NAFL, and the changes in individual PC, PE components demonstrated signifi-cant alteration in lipid metabolism in NASH patients, suggesting that abnormal phospholipid metabolism is involved in the tran-sition from NAFL to steatohepatitis. Furthermore, individual moi-eties of lipids which were either increased or decreased in NASH patients from this study were different from those previously re-ported [ 33,34 ]. Thus, our findings are additive to the previous stud-ies in terms of changes in specific individual lipid moieties in the transition from NAFL to NASH.

    With the availability of pathological evidence, we found that the changes in individual lipid moieties were correlated with the severity of NASH and fibrotic progression. Through cluster analysis combined with small lipid molecules in the correlation with NAS and fibrosis score, we found that PC (18:0/0:0) was positively cor-related with fibrosis score, and PC (14:0/18:2), PA (18:2/24:4) were positively correlated with NAS. Therefore, the lipid moieties may be non-invasive serum markers indicating NASH progression. This is a significant advance in this field, since, to our knowledge, this is the first study to reveal these correlations in NAFLD patients. Moreover, a combinatory modeling with 10 increased lipid species predicts the presence of liver fibrosis in NASH patients [11] . With healthy controls and a better cross-section study, polyunsaturated fatty acid metabolites, such as 13,14-dihydro-15-keto prostaglandin D2 (dhk PGD2) and 20-carboxy arachidonic acid (20-COOH AA) were found to be of diagnostic values for NAFL and NASH [36] .

    In conclusion, the findings of this study demonstrated overall lipidomic profile shift from NAFL to NASH, and identified valuable lipid moieties. The correlations of altered lipids to NAS and fibro-sis scores indicate differential value of these lipid biomarkers in NAFLD.

    Acknowledgments

    We are grateful to Prof. Hui-Yong Yin and his team from the Shanghai Life Science Institutes, Chinese Academy of Sciences, Shanghai, China for careful analysis of lipidomic and valuable assis-tance in data analysis. We are in debt to Prof. Xiu-Ping Liu from the Department of Pathology, Fudan University School of Basic Medical Sciences in helping with micrographs of histopathologic images.

    CRediT authorship contribution statement

    Zhong-Hua Wang :Data curation, Formal analysis, Investi-gation, Writing original draft.Kenneth I Zheng :Investigation.Xiao-Dong Wang :Investigation. Jin Qiao :Data curation, Formal analysis.Yang-Yang Li :Investigation.Li Zhang:Data curation, In-vestigation.Ming-Hua Zheng :Data curation, Investigation, Super-vision.Jian Wu :Conceptualization, Data curation, Funding acquisi-tion, Supervision, Writing review & editing.

    Funding

    This study was supported by grants from the Ministry of Sci-ence & Technology of China ( 2016YFE0107400 ), the National Nat-ural Science Foundation of China ( 81272436,81572356,81871997,81500 6 65 and 82070588 ) and High Level Creative Talents from De-partment of Public Health in Zhejiang Province (S203210260 0 032) and Project of New Century 551 Talent Nurturing in Wenzhou.

    Ethical approval

    The study was approved by the Institutional Review Board of the First Affiliated Hospital of Wenzhou Medical University and the Ethics Committee of Fudan University School of Basic Medical Sci-ences. In our study all subjects were collected in accordance with ethical guidelines, and written informed consent was received. All patients were approached based on approved ethical guidelines, and patients who agreed to participate in this study were required to sign consent forms before being included in the study.

    Competing interest

    No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the sub-ject of this article.

    Supplementary materials

    Supplementary material associated with this article can be found, in the online version, at doi: 10.1016/j.hbpd.2021.05.008 .

    久久久久久伊人网av| 久久久国产精品麻豆| 99久久精品一区二区三区| 99久久精品一区二区三区| 成年人免费黄色播放视频| 久久女婷五月综合色啪小说| 满18在线观看网站| 久久热精品热| 国产一区二区三区av在线| 国产精品成人在线| 国产精品一区二区三区四区免费观看| 色94色欧美一区二区| 久久99一区二区三区| 日韩中字成人| 一本—道久久a久久精品蜜桃钙片| 中国三级夫妇交换| 爱豆传媒免费全集在线观看| 五月玫瑰六月丁香| 69精品国产乱码久久久| 国产精品不卡视频一区二区| 亚洲成人av在线免费| 国产不卡av网站在线观看| 一级爰片在线观看| 大香蕉97超碰在线| 黄片播放在线免费| 久久久久久伊人网av| 一区二区三区精品91| 成人亚洲精品一区在线观看| 青春草视频在线免费观看| 嘟嘟电影网在线观看| 美女cb高潮喷水在线观看| 国产成人免费无遮挡视频| 大片电影免费在线观看免费| 婷婷色麻豆天堂久久| 99国产综合亚洲精品| 男人添女人高潮全过程视频| 欧美成人午夜免费资源| 丝袜在线中文字幕| 国产爽快片一区二区三区| 国产色爽女视频免费观看| 一区二区日韩欧美中文字幕 | 最近手机中文字幕大全| 亚洲精品第二区| 99久久人妻综合| 人妻 亚洲 视频| 国产一区二区三区综合在线观看 | av.在线天堂| 婷婷色麻豆天堂久久| 日本wwww免费看| √禁漫天堂资源中文www| 亚洲色图综合在线观看| 欧美 亚洲 国产 日韩一| 99热6这里只有精品| 三上悠亚av全集在线观看| 精品亚洲成国产av| 日韩精品免费视频一区二区三区 | 国产色婷婷99| 欧美激情 高清一区二区三区| 女人久久www免费人成看片| 亚洲国产精品一区二区三区在线| 只有这里有精品99| 日韩大片免费观看网站| 丰满乱子伦码专区| 少妇猛男粗大的猛烈进出视频| 免费日韩欧美在线观看| 99热全是精品| 亚洲国产精品国产精品| 成人午夜精彩视频在线观看| 国产成人一区二区在线| 天堂中文最新版在线下载| 两个人的视频大全免费| 天天操日日干夜夜撸| av播播在线观看一区| 亚洲精品乱久久久久久| 在线观看国产h片| 美女内射精品一级片tv| 狂野欧美激情性bbbbbb| 自线自在国产av| 考比视频在线观看| 伦理电影大哥的女人| 久久久久久久久久久久大奶| 最黄视频免费看| 国产精品免费大片| 中文字幕av电影在线播放| 免费日韩欧美在线观看| 欧美 日韩 精品 国产| 夜夜爽夜夜爽视频| 日韩,欧美,国产一区二区三区| 午夜福利在线观看免费完整高清在| 91国产中文字幕| 七月丁香在线播放| 亚洲国产精品一区三区| 亚洲精品国产av成人精品| 久久99热6这里只有精品| 精品亚洲成国产av| 精品少妇黑人巨大在线播放| 天堂中文最新版在线下载| 五月伊人婷婷丁香| 久久久精品94久久精品| 男男h啪啪无遮挡| 狂野欧美白嫩少妇大欣赏| 亚洲av在线观看美女高潮| 国产精品不卡视频一区二区| 精品熟女少妇av免费看| 欧美人与性动交α欧美精品济南到 | 国产高清国产精品国产三级| 精品国产国语对白av| 久久99热6这里只有精品| 一个人免费看片子| 伊人久久精品亚洲午夜| 成人毛片60女人毛片免费| 日韩伦理黄色片| 中文字幕最新亚洲高清| 亚洲精品国产av成人精品| 国产精品久久久久久久久免| h视频一区二区三区| 一级爰片在线观看| 99国产精品免费福利视频| 色94色欧美一区二区| 国产精品国产三级专区第一集| 一级毛片 在线播放| 综合色丁香网| 水蜜桃什么品种好| 国产亚洲av片在线观看秒播厂| 国产精品不卡视频一区二区| 熟女电影av网| 久久精品国产自在天天线| 久久久精品94久久精品| 中文字幕精品免费在线观看视频 | 99久久人妻综合| 欧美人与善性xxx| 天天操日日干夜夜撸| 99热网站在线观看| 欧美性感艳星| 欧美日韩av久久| 精品亚洲成国产av| 国产精品.久久久| 在线观看免费日韩欧美大片 | 国产高清三级在线| 久久久国产精品麻豆| 日本av免费视频播放| 激情五月婷婷亚洲| 一本一本综合久久| 蜜桃久久精品国产亚洲av| 麻豆成人av视频| 三级国产精品欧美在线观看| 国产av码专区亚洲av| 中文字幕制服av| 高清在线视频一区二区三区| 国产不卡av网站在线观看| 九九在线视频观看精品| 天堂中文最新版在线下载| 人人妻人人澡人人爽人人夜夜| 亚洲精品乱码久久久v下载方式| 色5月婷婷丁香| 久久久亚洲精品成人影院| 国产男人的电影天堂91| 毛片一级片免费看久久久久| 韩国高清视频一区二区三区| 精品人妻在线不人妻| av.在线天堂| 美女国产视频在线观看| 免费观看性生交大片5| 一区二区三区四区激情视频| 中文字幕精品免费在线观看视频 | 一级毛片 在线播放| 国产视频首页在线观看| 日韩免费高清中文字幕av| 国产欧美日韩一区二区三区在线 | 九九久久精品国产亚洲av麻豆| av国产精品久久久久影院| 午夜激情av网站| 一级爰片在线观看| 精品国产一区二区三区久久久樱花| 如日韩欧美国产精品一区二区三区 | 一区在线观看完整版| 精品久久久久久久久av| 一区二区三区四区激情视频| 97精品久久久久久久久久精品| 乱码一卡2卡4卡精品| 99国产精品免费福利视频| 汤姆久久久久久久影院中文字幕| 中文精品一卡2卡3卡4更新| 精品一区在线观看国产| 免费观看的影片在线观看| 欧美日韩亚洲高清精品| 午夜免费观看性视频| 夜夜看夜夜爽夜夜摸| 最黄视频免费看| 五月玫瑰六月丁香| 一本大道久久a久久精品| 黑人巨大精品欧美一区二区蜜桃 | 久久av网站| 午夜日本视频在线| 午夜久久久在线观看| 亚洲国产色片| 美女中出高潮动态图| 寂寞人妻少妇视频99o| 亚洲一级一片aⅴ在线观看| 最后的刺客免费高清国语| 国产乱人偷精品视频| 久久女婷五月综合色啪小说| 中文精品一卡2卡3卡4更新| 亚洲av综合色区一区| 中文字幕人妻丝袜制服| 中文字幕av电影在线播放| 日韩电影二区| 国产伦精品一区二区三区视频9| 精品一区二区三区视频在线| 夫妻性生交免费视频一级片| 欧美日韩视频高清一区二区三区二| 午夜福利视频在线观看免费| 亚洲精品日韩av片在线观看| 免费黄色在线免费观看| 欧美日本中文国产一区发布| 黑人猛操日本美女一级片| 自线自在国产av| 日韩人妻高清精品专区| 国产成人免费无遮挡视频| 精品人妻在线不人妻| 一区二区av电影网| 美女视频免费永久观看网站| 亚洲精品乱码久久久久久按摩| av卡一久久| av视频免费观看在线观看| 免费播放大片免费观看视频在线观看| 99热这里只有是精品在线观看| 国产男女超爽视频在线观看| 搡老乐熟女国产| 丁香六月天网| 看非洲黑人一级黄片| 精品人妻熟女av久视频| 午夜福利在线观看免费完整高清在| 观看美女的网站| 中文字幕久久专区| 国产成人91sexporn| 亚洲精品第二区| 亚洲色图综合在线观看| 欧美亚洲日本最大视频资源| 国产探花极品一区二区| 2022亚洲国产成人精品| 2018国产大陆天天弄谢| 一本久久精品| 91成人精品电影| 日本-黄色视频高清免费观看| 一本—道久久a久久精品蜜桃钙片| 王馨瑶露胸无遮挡在线观看| 十八禁高潮呻吟视频| 在线天堂最新版资源| 国产男人的电影天堂91| 黄色视频在线播放观看不卡| 国产精品国产av在线观看| 亚洲av国产av综合av卡| 久久人人爽av亚洲精品天堂| 婷婷色av中文字幕| 岛国毛片在线播放| 菩萨蛮人人尽说江南好唐韦庄| 国模一区二区三区四区视频| 久久国产精品男人的天堂亚洲 | 建设人人有责人人尽责人人享有的| 在线亚洲精品国产二区图片欧美 | 亚洲av男天堂| 国产av国产精品国产| 免费看av在线观看网站| 国产精品99久久久久久久久| av在线观看视频网站免费| 国产男女内射视频| 久久人人爽人人片av| 国产探花极品一区二区| 国产伦精品一区二区三区视频9| 精品久久久精品久久久| 国产淫语在线视频| 这个男人来自地球电影免费观看 | 国产亚洲一区二区精品| 成年人免费黄色播放视频| 国产伦精品一区二区三区视频9| 日韩欧美精品免费久久| 日韩精品免费视频一区二区三区 | 亚洲av日韩在线播放| 一级毛片电影观看| 特大巨黑吊av在线直播| 亚洲精品美女久久av网站| 一区二区日韩欧美中文字幕 | 国产片特级美女逼逼视频| 熟女av电影| 亚洲欧美成人综合另类久久久| 一本一本综合久久| 久久久久国产网址| 免费久久久久久久精品成人欧美视频 | 国产一区二区在线观看av| 国语对白做爰xxxⅹ性视频网站| 老女人水多毛片| 久久99精品国语久久久| 成人无遮挡网站| 色5月婷婷丁香| 国产极品天堂在线| 亚洲高清免费不卡视频| 18禁动态无遮挡网站| .国产精品久久| 国国产精品蜜臀av免费| 久久久精品区二区三区| 人妻制服诱惑在线中文字幕| 国产国语露脸激情在线看| 王馨瑶露胸无遮挡在线观看| 久久久精品免费免费高清| 午夜av观看不卡| 好男人视频免费观看在线| 久久精品国产亚洲av天美| 亚洲精品亚洲一区二区| 亚洲综合精品二区| 日韩一区二区视频免费看| 国产永久视频网站| av在线播放精品| 国产高清三级在线| 国产精品偷伦视频观看了| 2021少妇久久久久久久久久久| 久久婷婷青草| 哪个播放器可以免费观看大片| 精品卡一卡二卡四卡免费| 国产精品久久久久久久久免| 国产永久视频网站| 久久97久久精品| 亚洲少妇的诱惑av| 日韩人妻高清精品专区| 国产成人免费无遮挡视频| 在线观看人妻少妇| 国产一区二区三区综合在线观看 | 18禁裸乳无遮挡动漫免费视频| 亚洲五月色婷婷综合| 伦理电影大哥的女人| 国产日韩一区二区三区精品不卡 | 啦啦啦视频在线资源免费观看| 三上悠亚av全集在线观看| 寂寞人妻少妇视频99o| 视频中文字幕在线观看| 91成人精品电影| 国产熟女欧美一区二区| 日韩成人av中文字幕在线观看| 91成人精品电影| 精品亚洲成a人片在线观看| 欧美日韩综合久久久久久| 亚洲一级一片aⅴ在线观看| 最近手机中文字幕大全| 日韩,欧美,国产一区二区三区| 午夜久久久在线观看| 中文字幕制服av| 久久热精品热| 91在线精品国自产拍蜜月| 日本91视频免费播放| 国产精品成人在线| av不卡在线播放| 亚洲国产日韩一区二区| 日韩大片免费观看网站| 久久久久久久大尺度免费视频| 亚洲av日韩在线播放| 色婷婷av一区二区三区视频| 最后的刺客免费高清国语| 80岁老熟妇乱子伦牲交| 日产精品乱码卡一卡2卡三| 精品少妇内射三级| 青春草国产在线视频| 欧美激情国产日韩精品一区| 成人手机av| 亚洲,一卡二卡三卡| 自线自在国产av| 国产 一区精品| 国内精品宾馆在线| 日日摸夜夜添夜夜添av毛片| 高清av免费在线| 亚洲av在线观看美女高潮| 亚洲精品视频女| 亚洲成人手机| 免费人成在线观看视频色| 高清黄色对白视频在线免费看| 久久午夜福利片| 97超碰精品成人国产| 亚洲一级一片aⅴ在线观看| 国产精品久久久久久精品古装| 午夜福利在线观看免费完整高清在| 啦啦啦在线观看免费高清www| 中国三级夫妇交换| 91精品国产九色| 22中文网久久字幕| 一本大道久久a久久精品| 久久国产精品大桥未久av| 成人漫画全彩无遮挡| 亚洲少妇的诱惑av| 亚洲熟女精品中文字幕| 国产黄色视频一区二区在线观看| 波野结衣二区三区在线| 久久综合国产亚洲精品| 午夜福利视频在线观看免费| 国产熟女午夜一区二区三区 | 国国产精品蜜臀av免费| 麻豆乱淫一区二区| 免费av不卡在线播放| 九色成人免费人妻av| 欧美精品高潮呻吟av久久| 午夜av观看不卡| 中文字幕精品免费在线观看视频 | 国产一区二区三区综合在线观看 | 亚洲第一av免费看| 国产精品成人在线| 亚洲五月色婷婷综合| 午夜福利视频在线观看免费| 国产黄频视频在线观看| 午夜福利视频精品| 午夜福利,免费看| 欧美国产精品一级二级三级| 韩国av在线不卡| 欧美亚洲日本最大视频资源| 国产探花极品一区二区| 亚洲欧洲日产国产| 久久精品久久精品一区二区三区| 亚洲av福利一区| 午夜激情福利司机影院| 欧美日韩综合久久久久久| 久久影院123| 久久精品国产亚洲av天美| 天堂中文最新版在线下载| 天美传媒精品一区二区| 精品一区二区三卡| 国产国语露脸激情在线看| 一边摸一边做爽爽视频免费| 亚洲成色77777| 久久午夜综合久久蜜桃| 夜夜爽夜夜爽视频| 少妇人妻 视频| 秋霞在线观看毛片| 夜夜看夜夜爽夜夜摸| 中文字幕av电影在线播放| 亚洲精华国产精华液的使用体验| 国产欧美另类精品又又久久亚洲欧美| 三上悠亚av全集在线观看| 亚洲精品,欧美精品| 大香蕉97超碰在线| 人人妻人人澡人人爽人人夜夜| √禁漫天堂资源中文www| 在线观看一区二区三区激情| 好男人视频免费观看在线| 日韩视频在线欧美| 欧美国产精品一级二级三级| 欧美+日韩+精品| 91久久精品国产一区二区成人| 欧美日韩综合久久久久久| 免费日韩欧美在线观看| 日产精品乱码卡一卡2卡三| 91精品国产九色| 国产一区二区在线观看av| 国产日韩欧美在线精品| 青春草亚洲视频在线观看| 国产成人精品福利久久| 欧美 亚洲 国产 日韩一| 久久久亚洲精品成人影院| 另类精品久久| 色婷婷av一区二区三区视频| av专区在线播放| 丰满迷人的少妇在线观看| 成年人免费黄色播放视频| 一级毛片我不卡| 永久网站在线| 久久99热6这里只有精品| 久久精品久久久久久噜噜老黄| 免费黄频网站在线观看国产| 多毛熟女@视频| 国产精品99久久久久久久久| 午夜91福利影院| 边亲边吃奶的免费视频| 久久久精品区二区三区| 日本vs欧美在线观看视频| 精品视频人人做人人爽| 天美传媒精品一区二区| 夜夜看夜夜爽夜夜摸| 久久精品夜色国产| 少妇丰满av| 午夜影院在线不卡| 国产精品国产三级国产av玫瑰| 亚洲少妇的诱惑av| 亚洲av成人精品一二三区| 美女视频免费永久观看网站| 一区二区三区精品91| 51国产日韩欧美| 亚洲国产精品一区二区三区在线| 亚洲av免费高清在线观看| 狠狠婷婷综合久久久久久88av| 嫩草影院入口| 韩国av在线不卡| 久久久亚洲精品成人影院| 成年人午夜在线观看视频| 全区人妻精品视频| 高清不卡的av网站| 国产毛片在线视频| av天堂久久9| 久久婷婷青草| 亚洲国产欧美在线一区| 97在线人人人人妻| 国产国语露脸激情在线看| 国产精品久久久久久精品古装| 大香蕉久久成人网| 如何舔出高潮| 精品国产乱码久久久久久小说| 国产精品蜜桃在线观看| av播播在线观看一区| 亚洲av综合色区一区| 国产精品无大码| a级毛色黄片| 成人手机av| 久久久精品区二区三区| 国产黄色免费在线视频| 简卡轻食公司| 久久99一区二区三区| 一本一本综合久久| 精品国产露脸久久av麻豆| 大片免费播放器 马上看| 亚洲精品美女久久av网站| 色视频在线一区二区三区| 人人妻人人爽人人添夜夜欢视频| 国国产精品蜜臀av免费| 国产高清三级在线| 日韩中文字幕视频在线看片| 涩涩av久久男人的天堂| 久久精品久久久久久噜噜老黄| 欧美日韩亚洲高清精品| av免费观看日本| 香蕉精品网在线| 亚洲精品视频女| 亚洲五月色婷婷综合| 亚洲精品日韩在线中文字幕| 欧美xxxx性猛交bbbb| 日韩一本色道免费dvd| 熟女人妻精品中文字幕| 寂寞人妻少妇视频99o| 2021少妇久久久久久久久久久| 精品熟女少妇av免费看| 国产精品嫩草影院av在线观看| 只有这里有精品99| av黄色大香蕉| 一级二级三级毛片免费看| 高清午夜精品一区二区三区| 热re99久久精品国产66热6| 一本色道久久久久久精品综合| 人妻一区二区av| 免费观看的影片在线观看| 欧美日韩在线观看h| 在线观看一区二区三区激情| xxxhd国产人妻xxx| 高清黄色对白视频在线免费看| 特大巨黑吊av在线直播| 一级a做视频免费观看| 日韩熟女老妇一区二区性免费视频| 国产精品一区www在线观看| 国产欧美日韩综合在线一区二区| 一区二区日韩欧美中文字幕 | 亚洲国产精品一区三区| av.在线天堂| 欧美亚洲日本最大视频资源| 久久久国产一区二区| 少妇高潮的动态图| 97精品久久久久久久久久精品| www.色视频.com| 蜜桃在线观看..| 亚洲欧美清纯卡通| 欧美精品一区二区免费开放| 国产精品麻豆人妻色哟哟久久| 日本av手机在线免费观看| 两个人的视频大全免费| 免费黄网站久久成人精品| 伦理电影免费视频| 你懂的网址亚洲精品在线观看| 婷婷成人精品国产| 啦啦啦在线观看免费高清www| 国产在线免费精品| 最近2019中文字幕mv第一页| 搡女人真爽免费视频火全软件| 午夜视频国产福利| videossex国产| 天天躁夜夜躁狠狠久久av| 久久久精品区二区三区| 一区二区av电影网| 一级爰片在线观看| 国国产精品蜜臀av免费| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 成人二区视频| 国产一区二区三区av在线| 国产69精品久久久久777片| 美女主播在线视频| 久久精品国产亚洲av天美| 亚洲精品乱久久久久久| 黄色欧美视频在线观看| 一级毛片电影观看| 人妻一区二区av| 91精品伊人久久大香线蕉| 国产有黄有色有爽视频| 国产 精品1| 国产精品成人在线| av线在线观看网站| 自拍欧美九色日韩亚洲蝌蚪91| 18+在线观看网站| 亚洲精品av麻豆狂野| 久久人妻熟女aⅴ| 亚洲五月色婷婷综合| 26uuu在线亚洲综合色| 国产高清三级在线| 伦理电影免费视频| 国产成人精品福利久久| 大香蕉97超碰在线| 亚洲精品自拍成人| 成人二区视频| av免费在线看不卡| 亚洲人成网站在线观看播放| 一区二区三区四区激情视频| 国产熟女欧美一区二区| 国产亚洲一区二区精品| 精品久久久久久久久av| 国产熟女欧美一区二区|